Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of parkinson's disease patents

Patents where

Current Assignee

Industry

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11370832 Anti-Tau antibodies and methods of use thereof	Patent 11370832 was granted and assigned to Denali Therapeutics on June, 2022 by the United States Patent and Trademark Office.	Denali Therapeutics	Denali Therapeutics	United States Patent and Trademark Office	11370832	June 28, 2022
‌ US Patent 11931375 Treatment of amyotrophic lateral sclerosis (ALS)	Patent 11931375 was granted and assigned to Voyager Therapeutics on March, 2024 by the United States Patent and Trademark Office.	Voyager Therapeutics	Voyager Therapeutics	United States Patent and Trademark Office	11931375	March 19, 2024
‌ US Patent 11752181 Compositions and methods of treating Huntington's disease	Patent 11752181 was granted and assigned to Voyager Therapeutics on September, 2023 by the United States Patent and Trademark Office.	Voyager Therapeutics	Voyager Therapeutics	United States Patent and Trademark Office	11752181	September 12, 2023
‌ US Patent 11439629 Methods for the administration of certain VMAT2 inhibitors		Neurocrine Biosciences	Neurocrine Biosciences	United States Patent and Trademark Office	11439629	September 13, 2022
‌ US Patent 11326165 Methods and compositions for modulating splicing	Patent 11326165 was granted and assigned to Skyhawk Therapeutics on May, 2022 by the United States Patent and Trademark Office.	Skyhawk Therapeutics	Skyhawk Therapeutics	United States Patent and Trademark Office	11326165	May 10, 2022
‌ US Patent 11033563 Use of lactulose in the treatment of autism	Patent 11033563 was granted and assigned to Curemark on June, 2021 by the United States Patent and Trademark Office.	Curemark	Curemark	United States Patent and Trademark Office	11033563	June 15, 2021
‌ US Patent 11311532 High dosage valbenazine formulation and compositions, methods, and kits related thereto	Patent 11311532 was granted and assigned to Neurocrine Biosciences on April, 2022 by the United States Patent and Trademark Office.	Neurocrine Biosciences	Neurocrine Biosciences	United States Patent and Trademark Office	11311532	April 26, 2022
‌ US Patent 11434489 Methods and compositions for modulating splicing	Patent 11434489 was granted and assigned to Skyhawk Therapeutics on September, 2022 by the United States Patent and Trademark Office.	Skyhawk Therapeutics	Skyhawk Therapeutics	United States Patent and Trademark Office	11434489	September 6, 2022
‌ US Patent 10392380 Compounds	Patent 10392380 was granted and assigned to MISSION Therapeutics on August, 2019 by the United States Patent and Trademark Office.	MISSION Therapeutics	MISSION Therapeutics	United States Patent and Trademark Office	10392380	August 27, 2019
‌ US Patent 11603531 Methods and compositions for modulating splicing		Skyhawk Therapeutics	Skyhawk Therapeutics	United States Patent and Trademark Office	11603531	March 14, 2023
‌ US Patent 11326182 Compositions for the treatment of disease	Patent 11326182 was granted and assigned to Voyager Therapeutics on May, 2022 by the United States Patent and Trademark Office.	Voyager Therapeutics	Voyager Therapeutics	United States Patent and Trademark Office	11326182	May 10, 2022
‌ US Patent 9926307 Compounds	Patent 9926307 was granted and assigned to MISSION Therapeutics on March, 2018 by the United States Patent and Trademark Office.	MISSION Therapeutics	MISSION Therapeutics	United States Patent and Trademark Office	9926307	March 27, 2018
‌ US Patent 11541009 Methods of prophylaxis of coronavirus infection and treatment of coronaviruses	Patent 11541009 was granted and assigned to Curemark on January, 2023 by the United States Patent and Trademark Office.	Curemark	Curemark	United States Patent and Trademark Office	11541009	January 3, 2023
‌ US Patent 10004782 Glucokinase activator compositions for the treatment of diabetes	Patent 10004782 was granted and assigned to vTv Therapeutics on June, 2018 by the United States Patent and Trademark Office.	vTv Therapeutics	vTv Therapeutics	United States Patent and Trademark Office	10004782	June 26, 2018
‌ US Patent 9717710 Treatment of mild and moderate Alzheimer's disease	Patent 9717710 was granted and assigned to vTv Therapeutics on August, 2017 by the United States Patent and Trademark Office.	vTv Therapeutics	vTv Therapeutics	United States Patent and Trademark Office	9717710	August 1, 2017
‌ US Patent 11649230 Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof	Patent 11649230 was granted and assigned to vTv Therapeutics on May, 2023 by the United States Patent and Trademark Office.	vTv Therapeutics	vTv Therapeutics	United States Patent and Trademark Office	11649230	May 16, 2023
‌ US Patent 11130748 Compounds	Patent 11130748 was granted and assigned to MISSION Therapeutics on September, 2021 by the United States Patent and Trademark Office.	MISSION Therapeutics	MISSION Therapeutics	United States Patent and Trademark Office	11130748	September 28, 2021
‌ US Patent 10287284 Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof	Patent 10287284 was granted and assigned to vTv Therapeutics on May, 2019 by the United States Patent and Trademark Office.	vTv Therapeutics	vTv Therapeutics	United States Patent and Trademark Office	10287284	May 14, 2019
‌ US Patent 10889580 Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof	Patent 10889580 was granted and assigned to vTv Therapeutics on January, 2021 by the United States Patent and Trademark Office.	vTv Therapeutics	vTv Therapeutics	United States Patent and Trademark Office	10889580	January 12, 2021
‌ US Patent 11021708 Methods and compositions for modulating splicing	Patent 11021708 was granted and assigned to Skyhawk Therapeutics on June, 2021 by the United States Patent and Trademark Office.	Skyhawk Therapeutics	Skyhawk Therapeutics	United States Patent and Trademark Office	11021708	June 1, 2021
‌ US Patent 10363244 Compositions comprising metformin and a glucokinase activator	Patent 10363244 was granted and assigned to vTv Therapeutics on July, 2019 by the United States Patent and Trademark Office.	vTv Therapeutics	vTv Therapeutics	United States Patent and Trademark Office	10363244	July 30, 2019
‌ US Patent 9359313 Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator	Patent 9359313 was granted and assigned to vTv Therapeutics on June, 2016 by the United States Patent and Trademark Office.		vTv Therapeutics	United States Patent and Trademark Office	9359313	June 7, 2016
‌ US Patent 9447468 Compounds that modulate oxidative stress	Patent 9447468 was granted and assigned to vTv Therapeutics on September, 2016 by the United States Patent and Trademark Office.	vTv Therapeutics	vTv Therapeutics	United States Patent and Trademark Office	9447468	September 20, 2016
‌ US Patent 9707239 Compounds that modulate oxidative stress	Patent 9707239 was granted and assigned to vTv Therapeutics on July, 2017 by the United States Patent and Trademark Office.	vTv Therapeutics	vTv Therapeutics	United States Patent and Trademark Office	9707239	July 18, 2017
‌ US Patent 10457717 Engineered polypeptides	Patent 10457717 was granted and assigned to Denali Therapeutics on October, 2019 by the United States Patent and Trademark Office.	Denali Therapeutics	Denali Therapeutics	United States Patent and Trademark Office	10457717	October 29, 2019

...

Results per page:

231 results

0 selected

231 results

0 selected